Literature DB >> 19962482

Comparison of the results of aortic valve replacement with or without concomitant coronary artery bypass grafting in patients with left ventricular ejection fraction < or =30% versus patients with ejection fraction >30%.

Joanna Chikwe1, Lori B Croft, Andrew B Goldstone, Javier G Castillo, Parwis B Rahmanian, David H Adams, Farzan Filsoufi.   

Abstract

The present study was designed to test the hypothesis that low-ejection fraction (EF), low-gradient aortic stenosis (AS) is a predictor of major morbidity after aortic valve replacement (AVR). We retrospectively analyzed prospectively collected data from 597 consecutive patients with AS (mean age 72 +/- 11 years) who had undergone AVR or combined AVR and coronary artery bypass grafting (CABG) from 1998 to 2006 (EF < or =30% in 73 [12%]). The outcome measures included hospital mortality, major complications, and long-term survival. The overall hospital mortality rate was 4% (low-EF AS 5%; low-EF AS plus CABG 8%; AS controls 4%; AS plus CABG controls 3%; p = 0.42). Low-EF, low-gradient AS was not an independent risk factor for hospital mortality but predicted stroke (odds ratio [OR] 4.3), deep sternal wound infection (OR 10.0), sepsis (OR 6.8), gastrointestinal complications (OR 4.2), and respiratory failure (OR 4.4). The survival rate at 1, 3, and 5 years was 69 +/- 8%, 69 +/- 8%, and 65 +/- 8% in the low-EF, low-gradient, AVR plus CABG group and 95 +/- 4%, 92 +/- 5%, and 82 +/- 7% in the low-EF, low-gradient AVR group compared to 93 +/- 2%, 88 +/- 2%, and 78 +/- 3% in the AVR plus CABG control group and 93 +/- 2%, 89 +/- 2%, and 85 +/- 3% in the AVR control group (p = 0.001), respectively. In the patients with low-EF AS who experienced major postoperative morbidity, the 1-year survival rate was significantly reduced (54 +/- 14%) compared to those who did not (95 +/- 3%, p <0.001). In conclusion, low-EF, low-gradient AS is a predictor of increased major morbidity after AVR, which nonetheless remains the treatment of choice for most patients because of the excellent early and late survival. However, patients with strong risk factors for postoperative renal and respiratory failure might derive less benefit from conventional surgical AVR.

Entities:  

Mesh:

Year:  2009        PMID: 19962482     DOI: 10.1016/j.amjcard.2009.07.059

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Long-term outcomes of isolated aortic valve replacement and concomitant AVR and coronary artery bypass grafting.

Authors:  G A de Waard; E K Jansen; M de Mulder; A B A Vonk; V A Umans
Journal:  Neth Heart J       Date:  2012-03       Impact factor: 2.380

2.  Sex, aging, and preexisting cerebral ischemic disease in patients with aortic stenosis.

Authors:  Ping Wang; Michael A Acker; Michel Bilello; Elias R Melhem; Elizabeth Stambrook; Sarah J Ratcliffe; Thomas F Floyd
Journal:  Ann Thorac Surg       Date:  2010-10       Impact factor: 4.330

Review 3.  Risk factors for postoperative respiratory mortality and morbidity in patients undergoing coronary artery bypass grafting.

Authors:  Samira Rajaei; Ali Dabbagh
Journal:  Anesth Pain Med       Date:  2012-09-13

4.  The impact of coronary artery disease severity on late survival after combined aortic valve replacement and coronary artery bypass grafting - experience of a single cardiac surgery center.

Authors:  Bartłomiej Perek; Marcin Misterski; Wojciech Stachowiak; Piotr Buczkowski; Sebastian Stefaniak; Mateusz Puślecki; Tomasz Urbanowicz; Wiktor Budniak; Marek Jemielity
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-11-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.